Psychotropic Medicines: Reviewing with Care Home Residents (547) | Right Decisions

Right Decisions
Shared content
Back
GGC - Clinical guidelines
Psychotropic Medicines: Reviewing with Care Home Residents (547)

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Who is this guidance for?

It is intended as a resource to assist medical and non-medical healthcare professionals’ decision making process when reviewing psychotropic medicines with Care Home residents, and where appropriate carers and welfare proxies e.g. those with power of attorney regarding health related issues.

What is in the guidance?

Quick reference guide for issues to consider bio-psycho-social factors identifying and when managing symptoms of stress and distress in dementia.
Provides information and considerations in relation to antidepressant, benzodiazepines, z-hypnotics, cognitive enhancers and mood stabilisers, and links to antipsychotic prescribing guidance in dementia guideline in a new window.

Resources

Use the button below to access this item.

Access this resource

Last reviewed: 30/04/2024

Next review date: 10/04/2027

Author(s): Chris Johnson.

Version: 3

Author email(s): christopher.johnson@ggc.scot.nhs.uk.

Approved By: Prescribing Management Group

Reviewer name(s): Chris Johnson.

Document Id: 547